drugset / Trial / NCT06658964
Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the effects of oral administration rifampicin or itraconazole capsules on the pharmacokinetics of JMKX003142 in healthy subjects.
Timeline
- Start
- 2024-11-05
- Primary completion
- 2024-12-10
- Completion
- 2025-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | — |
| Subject | JMKX003142 | Unknown | 3 mg | — |
| Subject | JMKX003142 | Unknown | 6 mg | — |
| Subject | Rifampin | Small molecule | 600 mg | — |